Enanta Pharmaceuticals Inc (ENTA) Insider Trading
- $2,977,699.00
- $79,185,855.68
- Dec. 13, 2023
- Paul J Mellett
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| June 5, 2015 | Insider | 10,750 | $42.02 | Sell | $451,715.00 | |
| May 19, 2015 | CFO | 24,000 | $40.13 | Sell | $963,120.00 | |
| May 11, 2015 | Insider | 8,000 | $36.13 | Sell | $289,040.00 | |
| March 9, 2015 | CEO | 15,000 | $33.37 | Sell | $500,550.00 | |
| Feb. 20, 2015 | CEO | 15,000 | $35.35 | Sell | $530,250.00 | |
| Feb. 19, 2015 | Director | 1,000 | $34.00 | Buy | $34,000.00 | |
| Feb. 17, 2015 | VP | 1,400 | $33.23 | Buy | $46,522.00 | |
| Jan. 16, 2015 | CFO | 4,500 | $49.45 | Sell | $222,525.00 | |
| Jan. 5, 2015 | CEO | 15,000 | $50.43 | Sell | $756,450.00 | |
| Dec. 1, 2014 | CEO | 15,000 | $45.39 | Sell | $680,850.00 | |
| Nov. 3, 2014 | CEO | 15,000 | $42.52 | Sell | $637,800.00 | |
| Sept. 15, 2014 | CFO | 10,000 | $39.83 | Sell | $398,300.00 | |
| Aug. 14, 2014 | CFO | 10,000 | $39.13 | Sell | $391,300.00 | |
| Aug. 14, 2014 | Director | 1,000 | $38.95 | Buy | $38,950.00 | |
| July 14, 2014 | CFO | 20,000 | $39.88 | Sell | $797,600.00 | |
| May 1, 2014 | Insider | 5,000 | $36.98 | Sell | $184,900.00 | |
| April 1, 2014 | Insider | 10,000 | $39.16 | Sell | $391,600.00 | |
| April 1, 2014 | CEO | 15,000 | $39.17 | Sell | $587,550.00 | |
| March 24, 2014 | Insider | 10,000 | $39.34 | Sell | $393,400.00 | |
| March 4, 2014 | major shareholder | 439,334 | $38.82 | Sell | $17,054,945.88 | |
| Feb. 26, 2014 | major shareholder | 230,190 | $39.15 | Sell | $9,011,938.50 | |
| Feb. 24, 2014 | major shareholder | 60,477 | $39.57 | Sell | $2,393,074.89 | |
| Feb. 14, 2014 | CEO | 5,800 | $38.10 | Sell | $220,980.00 | |
| Jan. 2, 2014 | CEO | 5,800 | $28.05 | Sell | $162,690.00 | |
| Dec. 6, 2013 | Director | 6,861 | $27.93 | Sell | $191,627.73 | |
| Oct. 14, 2013 | Major Shareholder | 32,301 | $19.84 | Sell | $640,851.84 | |
| Oct. 10, 2013 | Major Shareholder | 36,207 | $21.71 | Sell | $786,053.97 | |
| Oct. 3, 2013 | Major Shareholder | 12,300 | $23.39 | Sell | $287,697.00 | |
| March 26, 2013 | Director | 132,949 | $14.00 | Buy | $1,861,286.00 | |
| March 26, 2013 | Major Shareholder | 66,474 | $14.00 | Buy | $930,636.00 |
Insiders are both buying and selling Enanta Pharmaceuticals Inc stock.
The insider traders at Enanta Pharmaceuticals Inc are: Nathalie Adda, Paul J Mellett, Yat Sun Or, Jay R Luly, Saints Capital Granite, L.P., Bruce L A Carter, V Life Science Ventures Gm Tvm, Paul J. Mellett, Nathaniel S Gardiner, Jay Luly, Stephen Jr. Buckley, Terry Vance, Scott T Rottinghaus, Brendan Luu, Helmut Schuhsler, Tim Ocain, George Golumbeski, and Marc E Goldberg
The most active insider trader at Enanta Pharmaceuticals Inc is Nathalie Adda with 14 trades.
V Life Science Ventures Gm Tvm has sold the most Enanta Pharmaceuticals Inc stock with a total value of $45,514,905.15.
Helmut Schuhsler has bought the most Enanta Pharmaceuticals Inc stock with a total value of $3,722,572.00.
The most recent insider trade for Enanta Pharmaceuticals Inc was on Dec. 13, 2023.
The single biggest insider buy for Enanta Pharmaceuticals Inc was from Helmut Schuhsler with a total value of $1,861,286.00 on March 26, 2013.
The single biggest insider sell for Enanta Pharmaceuticals Inc was from V Life Science Ventures Gm Tvm with a total value of $17,054,945.88 on March 4, 2014.